Abstract

Prednisolone 1 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: May/Jun 2020 - Volume 24, Number 3

Page(s): 229

Download in electronic PDF format for $75
  • Prednisolone 1 mg/mL in SyrSpend SF pH4 Page 1

Abstract

A formulation for preparing Prednisolone 1 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • prednisolone
  • corticosteroid
  • anti-inflammatory agent
  • inflammation
  • inflammatory disorders
  • edema
  • allergic reactions
  • skin disorders
  • endocrine disorders
  • ulcerative colitis
  • blood disorders
  • cancer
  • multiple sclerosis
  • eye disorders
  • lung disorders
  • rheumatic disorders

Related Categories

  • DERMATOLOGY
  • FORMULATIONS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2020
Pg. 229
Prednisolone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 487
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Jul/Aug 2011
Pg. 340
Methylprednisolone 4-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 302-307
Treating Inner Ear Disorders with Intratympanic Drug Administration
Author(s): McElhiney Linda F
Jul/Aug 2005
Pg. 275-278
Compounding for Endocrine Disorders in Adult Patients
Author(s): Grajeda Betty Jo, Vail Jane
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 1997
Pg. 87-89
Attention Deficit Hyperactivity Disorder
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 315
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 491
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 225
Dexamethasone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2010
Pg. 171-173
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
Sep/Oct 2021
Pg. 417
Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton
Jan/Feb 2007
Pg. 78
Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 57
Sodium Citrate 9% Nasal Spray for Olfactory Disorders
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 490
Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr